Maisel S, Broka D, Atwell B, Bunch T, Kupp R, Singh SK, Mehta S, Schroeder JA. (2019) Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer. J Transl Med. 17(1):201.

Maisel S, Schroeder JA. (2019) Wrong place at the wrong time: how retrograde trafficking drives cancer metastasis through receptor mislocalization. J Cancer Metastasis Treat.

Maisel S, Broka D, Schroeder JA. (2017) Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth factor-dependent migration. Oncotarget. 9(5):6463-6477.

Greenwood E, Maisel* S, Ebertz* D, Russ A, Pandey R, Schroeder JA. (2016) Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration. Oncotarget. 7(38):60776-60792.

Hart* M, Su* H-Y, Broka D, Goverdhan A, Schroeder JA. (2013) Inactive ERBB dimer formation cooperates with reactive oxygen species to supress cancer progression. Molecular Therapeutics. 21(11):1996-2007.

Horm TM, Schroeder JA. (2013) MUC1 and metastatic cancer: expression, function, and therapeutic targeting. Cell Adhesion and Migration. 7(2):187-98.

Russ A, Louderbough JM, Zarnescu D, Schroder JA. (2012) Hugl1 and Hugl2 in mammary epithelial cells: polarity, proliferation, and differentiation. PLoS One. 7(10): e47734.

Horm TM, Bitler BG, Broka DM, Louderbough JM, Schroeder JA. (2012) MUC1 drives c-Met-dependent migration and scattering. Molecular Cancer Research. Nov 27; 10(12):1544-54.

Louderbough JM, Schroeder JA. (2011) Understanding the dual nature of CD44 in breast cancer progression. Molecular Cancer Research. 9(12): 1573-86.

Zheng X, Cheung LSL, Schroeder JA, Jiang L, Zohar Y. (2011) Cell receptor and surface ligand density effects on dynamic states of adhering circulating tumor cells. Lab on a Chip. 11:3431-9.

Louderbough JM, Brown JA, Nagel RB, Schroeder JA. (2011) CD44 promotes epithelial mammary gland development and exhibits altered localization during cancer progression. Genes & Cancer. 2(8): 771-781.

Zheng X, Cheung LSL, Schroeder JA, Jiang L, Zohar Y. (2011) A high-performance microsystem for isolating circulating tumor cells. Lab on a Chip. 11:3269-76.

Cheung LSL, Zheng X, Wang L, Baygents JC, Guzman R, Schroeder JA, Heimark RL, Zohar Y. (2011) Adhesion dynamics of circulating tumor cells under shear flow in a bio-functionalized microchannel. Journal of Micromechanics and Microengineering. 21:354033.

Cheung LSL, Zheng X, Wang L, Guzman R, Schroeder JA, Heimark RL, Zohar Y. (2010) Kinematics of specifically captured circulating tumor cells in bio-functionalized microchannels. Journal of Microelectromechanical Systems. 19:752-763.

Flowers M, Schroeder JA, Borowsky AD, Besselsen DG, Thompson CA, Pandev R, Thompson PA. (2010) Pilot study on the effects of dietary conjugated linoleic acid on tumorigenesis and gene expression in PyMT transgenic mice. Carcinogenesis. 31:1642-9.

Bitler BG, Goverdhan A, Schroeder JA. (2010) MUC1 regulates nuclear localization and function of the epidermal growth factor receptor. Journal of Cell Science. 123(10):1716-23.

Louderbough JMV, Lopez JI, Schroeder JA. (2010) Matrix hyaluronan alters epidermal growth factor receptor-dependent cell morphology. Cell Adhesion and Migration. 4:26-31.

Bitler BG, Schroeder JA. (2010) Anti-cancer therapies that utilize cell penetrating peptides. Recent Patents on Anticancer Drug Discovery. 5(2): 99-108.

Cheung LSL, Zheng X, Stopa A, Baygents JC, Guzman R, Schroeder JA, Heimark RL, Zohar Y. (2009) Detachment of captured cancer cells under flow acceleration in a bio-functionalized microchannel. Lab on a Chip. 9:1721-31.

Bitler BG, Menzl I, Huerta CL, Sands B, Knowlton W, Chang A, and Schroeder JA. (2009) Intracellular MUC1 peptides inhibit cancer progresssion. Clinical Cancer Research. 15(1):100-9.

Pochampalli MR, Bitler BG, Schroeder JA. (2007) Transforming growth factor alpha dependent cancer progression is modulated by Muc1. Cancer Research. Jul 15;67(14):6591-8.

Pochampalli* MR, Bejjani* RM, Schroeder JA. (2007) MUC1 is a novel regulator of ErbB1 receptor trafficking. Oncogene. 26(12):1693-1701.

Lopez* JI, Camenisch* TD, Stevens MV, Sands BJ, McDonald J, Schroeder JA. (2005) CD44 attenuates metastatic invasion during breast cancer progression.Cancer Research. 65(15):6755-63.